Global Tuberculosis Prevention and Treatment Vaccine Market Growth 2022-2028
SKU ID : LPI-20383432 | Publishing Date : 03-Mar-2022 | No. of pages : 101
Detailed TOC of Global Tuberculosis Prevention and Treatment Vaccine Market Growth 2022-2028
1 Scope of the Report1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Tuberculosis Prevention and Treatment Vaccine Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 Tuberculosis Prevention and Treatment Vaccine Sales by Type
2.3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2017-2022)
2.4 Tuberculosis Prevention and Treatment Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 Tuberculosis Prevention and Treatment Vaccine Sales by Application
2.5.1 Global Tuberculosis Prevention and Treatment Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2017-2022)
3 Global Tuberculosis Prevention and Treatment Vaccine by Company
3.1 Global Tuberculosis Prevention and Treatment Vaccine Breakdown Data by Company
3.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2020-2022)
3.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company
3.4 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Location Distribution
3.4.2 Players Tuberculosis Prevention and Treatment Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tuberculosis Prevention and Treatment Vaccine by Geographic Region
4.1 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Geographic Region
4.2 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Country/Region
4.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.4 APAC Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.5 Europe Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.6 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Growth
5 Americas
5.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country
5.1.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022)
5.1.2 Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022)
5.2 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type
5.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region
6.1.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2017-2022)
6.1.2 APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2017-2022)
6.2 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type
6.3 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tuberculosis Prevention and Treatment Vaccine by Country
7.1.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022)
7.1.2 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022)
7.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type
7.3 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine by Country
8.1.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type
8.3 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine
10.3 Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
10.4 Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Prevention and Treatment Vaccine Distributors
11.3 Tuberculosis Prevention and Treatment Vaccine Customer
12 World Forecast Review for Tuberculosis Prevention and Treatment Vaccine by Geographic Region
12.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region
12.1.1 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Region (2023-2028)
12.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Type
12.7 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Prevention and Treatment Vaccine Product Offered
13.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Offered
13.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Offered
13.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Offered
13.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Offered
13.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Offered
13.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Offered
13.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Offered
13.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Offered
13.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Offered
13.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Product Offered
13.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Offered
13.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Product Offered
13.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 Research Findings and Conclusion
List of Figures, Tables and Charts Available in Global Tuberculosis Prevention and Treatment Vaccine Market Growth 2022-2028
List of TablesTable 1. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players of Therapy Vaccine
Table 5. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2017-2022)
Table 13. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Tuberculosis Prevention and Treatment Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution and Sales Area
Table 21. Players Tuberculosis Prevention and Treatment Vaccine Products Offered
Table 22. Tuberculosis Prevention and Treatment Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tuberculosis Prevention and Treatment Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Tuberculosis Prevention and Treatment Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Tuberculosis Prevention and Treatment Vaccine
Table 66. Key Market Challenges & Risks of Tuberculosis Prevention and Treatment Vaccine
Table 67. Key Industry Trends of Tuberculosis Prevention and Treatment Vaccine
Table 68. Tuberculosis Prevention and Treatment Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Tuberculosis Prevention and Treatment Vaccine Distributors List
Table 71. Tuberculosis Prevention and Treatment Vaccine Customer List
Table 72. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Forecast by Region
Table 74. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 94. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Japan BCG Lab Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 99. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Japan BCG Lab Main Business
Table 101. Japan BCG Lab Latest Developments
Table 102. Serum Institute of India Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 104. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Serum Institute of India Main Business
Table 106. Serum Institute of India Latest Developments
Table 107. AJ Vaccines Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 109. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. AJ Vaccines Main Business
Table 111. AJ Vaccines Latest Developments
Table 112. BioFarma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 114. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. BioFarma Main Business
Table 116. BioFarma Latest Developments
Table 117. GreenSignal Bio Pharma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 119. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. GreenSignal Bio Pharma Main Business
Table 121. GreenSignal Bio Pharma Latest Developments
Table 122. China National Biotec Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 124. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. China National Biotec Main Business
Table 126. China National Biotec Latest Developments
Table 127. Biomed Lublin Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 129. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Biomed Lublin Main Business
Table 131. Biomed Lublin Latest Developments
Table 132. Taj Pharmaceuticals Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 134. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Taj Pharmaceuticals Main Business
Table 136. Taj Pharmaceuticals Latest Developments
Table 137. Ataulpho de Paiva Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 139. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Ataulpho de Paiva Main Business
Table 141. Ataulpho de Paiva Latest Developments
Table 142. IVAC Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. IVAC Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 144. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. IVAC Main Business
Table 146. IVAC Latest Developments
Table 147. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 149. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Queen Saovabha Mem. Inst Main Business
Table 151. Queen Saovabha Mem. Inst Latest Developments
Table 152. Microgen Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Microgen Tuberculosis Prevention and Treatment Vaccine Product Offered
Table 154. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Microgen Main Business
Table 156. Microgen Latest Developments
List of Figures
Figure 1. Picture of Tuberculosis Prevention and Treatment Vaccine
Figure 2. Tuberculosis Prevention and Treatment Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tuberculosis Prevention and Treatment Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Immune Vaccine
Figure 10. Product Picture of Therapy Vaccine
Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type in 2021
Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Tuberculosis Prevention and Treatment Vaccine Consumed in Self-Procurement
Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Market: Self-Procurement (2017-2022) & (K Units)
Figure 15. Tuberculosis Prevention and Treatment Vaccine Consumed in UNICEF
Figure 16. Global Tuberculosis Prevention and Treatment Vaccine Market: UNICEF (2017-2022) & (K Units)
Figure 17. Tuberculosis Prevention and Treatment Vaccine Consumed in Other
Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Market: Other (2017-2022) & (K Units)
Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application in 2021
Figure 21. Tuberculosis Prevention and Treatment Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)
Figure 28. Americas Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)
Figure 30. APAC Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)
Figure 32. Europe Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
Figure 65. Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles